Evaluation of MicroRNA Expression in Blood and Cytology for Detecting Barrett's Esophagus and Associated Neoplasia
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02464930 |
Recruitment Status
:
Recruiting
First Posted
: June 8, 2015
Last Update Posted
: June 8, 2015
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Barrett's Esophagus Gastroesophageal Reflux Esophageal Adenocarcinoma |
Study Type : | Observational |
Estimated Enrollment : | 220 participants |
Observational Model: | Case Control |
Time Perspective: | Prospective |
Official Title: | Evaluation of MicroRNA Expression in Blood and Cytology Specimens as a Novel Method for Detecting Barrett's Esophagus |
Study Start Date : | April 2015 |
Estimated Primary Completion Date : | April 2018 |
Estimated Study Completion Date : | December 2018 |
Group/Cohort |
---|
No-GERD Controls
NERD controls will be enrolled from subjects presenting to the endoscopy unit who are being evaluated for reasons other than GERD or BE surveillance. These are patients who are referred to the endoscopy unit for: evaluation of anemia, dysphagia, occult blood positivity, gastrointestinal blood loss etc.
|
GERD Controls
|
BE Cases
• Patients who present for evaluation of reflux symptoms and are found to have at least 1 cm of columnar lined esophagus on endoscopy with intestinal metaplasia on biopsies. This will include patients with esophageal adenocarcinoma
|
- Sensitivity and specificity of tissue and serum microRNA expression by digital polymerase chain reaction for diagnosis of BE neoplasia [ Time Frame: 1-3 years ]The two main outcomes are the diagnostic accuracy of tissue and serum microRNA for the the diagnosis of Barrett's esophagus compared to endoscopy.
- Differences in the microRNA expression of biliary exosomes between GERD, Barrett's esophagus and Cancer [ Time Frame: 1-3 years ]The microRNA expression will be measured by digital polymerase chain reaction
Biospecimen Retention: Samples With DNA

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Senior) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Patient age: > 18 years
- Ability to provide written, informed consent
Exclusion Criteria:
- Pregnancy or planning a pregnancy
- History of nasal, esophageal & gastric surgery
- History of recurrent epistaxis or nasal trauma
- Subjects with a history of unresolved drug or alcohol dependency
- Inability to obtain biopsies due to a coagulopathy, varices, thrombocytopenia, etc.
- Subjects with inadequate cytology specimens will not undergo repeat test and will be excluded from the study
- Inability to provide written informed consent
- Inability to discontinue drugs such as Plavix
- Advanced chronic liver disease
- Severe uncontrolled coagulopathy
- Active cancer in any organ over the past 3 years.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02464930
Contact: Ajay Bansal, MD | 57790 | ajay.bansal@va.gov | |
Contact: Andrew Price, BS | 56428 | andrew.price@va.gov |
United States, Missouri | |
Kansas City Veterans Affairs Medical Center | Recruiting |
Kansas City, Missouri, United States, 64128 | |
Contact: AJAY BANSAL, MD 816-861-4700 ext 57790 Ajay.Bansal@va.gov | |
Contact: Andrew Price, AS 816-861-4700 ext 56428 Andrew.Price2@va.gov | |
Principal Investigator: Ajay Bansal |
Principal Investigator: | Ajay Bansal, MD | Veterans Affairs Medical Center and the University of Kansas Medical Center |
Publications:
Responsible Party: | Ajay Bansal, Associate Professor of Medicine and Staff Gastroenterologist, Midwest Biomedical Research Foundation |
ClinicalTrials.gov Identifier: | NCT02464930 History of Changes |
Other Study ID Numbers: |
AB0009 |
First Posted: | June 8, 2015 Key Record Dates |
Last Update Posted: | June 8, 2015 |
Last Verified: | June 2015 |
Keywords provided by Ajay Bansal, Midwest Biomedical Research Foundation:
Blood Cytology Esophagus microRNA |
Additional relevant MeSH terms:
Adenocarcinoma Gastroesophageal Reflux Barrett Esophagus Esophageal Neoplasms Carcinoma Neoplasms, Glandular and Epithelial Neoplasms by Histologic Type Neoplasms Esophageal Motility Disorders |
Deglutition Disorders Esophageal Diseases Gastrointestinal Diseases Digestive System Diseases Digestive System Abnormalities Gastrointestinal Neoplasms Digestive System Neoplasms Neoplasms by Site Head and Neck Neoplasms |